tradingkey.logo
tradingkey.logo
Search

Hoth Therapeutics (Hoth) Reports Positive Ht-Va Crada Data Gdnf Reprograms Liver Fat Metabolism, Shuts Down Fat-Creation Gene And Activates Fat-Burning Pathways, Outperforming Semaglutide

ReutersApr 13, 2026 9:25 PM
facebooktwitterlinkedin

- Hoth Therapeutics Inc HOTH.O:

  • HOTH THERAPEUTICS (HOTH) REPORTS POSITIVE HT-VA CRADA DATA: GDNF REPROGRAMS LIVER FAT METABOLISM, SHUTS DOWN FAT-CREATION GENE AND ACTIVATES FAT-BURNING PATHWAYS, OUTPERFORMING SEMAGLUTIDE

  • HOTH THERAPEUTICS INC - GDNF SHOWS SIGNIFICANT SREBF1 REDUCTION AND PPARΑ INCREASE IN MAFLD AND OBESITY MODEL

  • HOTH THERAPEUTICS INC - GDNF OUTPERFORMS SEMAGLUTIDE IN GENE MARKERS RELATED TO LIVER FAT REGULATION

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Tradingkey
KeyAI